RIP3 Cancer Research Results
RIP3, Receptor‐Interacting Protein Kinase 3: Click to Expand ⟱
| Source: |
| Type: |
RIP3 Receptor‐Interacting Protein Kinase 3
Several cancers have decreased RIP3 expression and is associated with poorer prognosis, more aggressive tumor behavior, and resistance to chemotherapies. Restoration of RIP3 may promote necroptosis, providing a potential mechanism to overcome therapy resistance.
|
BC, Breast Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
vitro+vivo, |
BC, |
MDA-MB-231 |
|
|
|
TumCP↓, Apoptosis↑, Necroptosis↑, TumAuto↑, Akt↓, BAX↑, cl‑Casp3↑, RIP3↑, p‑RIP3↑, MLKL↑, LC3‑Ⅱ/LC3‑Ⅰ↑, mtDam↑, ATP↓, ROS↑, TumCG↓,
TumCCA↑, Casp↑, Apoptosis↑, Necroptosis↑, RIP1↓, RIP3↑, MLKL↑, ROS↑, eff↓,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↑, 2,
Mitochondria & Bioenergetics(tgid=3) ⓘ
ATP↓, 1, mtDam↑, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, Apoptosis↑, 2, BAX↑, 1, Casp↑, 1, cl‑Casp3↑, 1, MLKL↑, 2, Necroptosis↑, 2, RIP1↓, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
LC3‑Ⅱ/LC3‑Ⅰ↑, 1, TumAuto↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
TumCG↓, 1,
Migration(tgid=13) ⓘ
RIP3↑, 2, p‑RIP3↑, 1, TumCP↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
eff↓, 1,
Total Targets: 19
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: RIP3, Receptor‐Interacting Protein Kinase 3
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:4 Cells:% prod#:% Target#:1066 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page